Cercare

I tuoi risultati

Visualizza 10 su 17 risultati

In September 2020, as part of the fight against cancer and to protect the health of workers in a number of industries, the European Commission proposed to amend the Carcinogens and Mutagens Directive (Directive 2004/37/EC), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. On 16 December 2021, after interinstitutional negotiations, the Council and the European Parliament reached a provisional agreement ...

È in corso il quarto aggiornamento della direttiva sugli agenti cancerogeni e mutageni, che si iscrive nell'ambito della lotta contro il cancro e della tutela della salute dei lavoratori in diversi settori. Un accordo a livello di trilogo sulla proposta stabilisce nuovi limiti di esposizione per una serie di sostanze pericolose. Il Parlamento europeo dovrebbe votare l'accordo provvisorio durante la tornata di febbraio.

L'amianto è una delle principali cause dei tumori professionali, nonostante il suo divieto in tutta l'UE nel 2005. I rischi legati all'amianto persistono e costituiranno un fattore di rischio per la salute nel contesto dell'ondata di ristrutturazioni del Green Deal europeo, volta a contribuire a rendere gli edifici adatti a un'Europa climaticamente neutra. Una relazione di iniziativa legislativa contenente proposte per una "Strategia europea per la rimozione dell'amianto" (ESRAA) dovrebbe essere ...

Protecting workers from asbestos

Analisi approfondita 29-03-2021

Asbestos is responsible for more than half of the deaths from occupational cancer in the world. Since 2005 Asbestos is banned in Europe. The risks remain, because of the maintenance or demolition work on older buildings and their renovation (increasing energy efficiency) result in substantial exposure to asbestos and many people still work and live in asbestos contaminated buildings.

The impact assessment (IA) defines clearly the problem and its underlying drivers. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable and/or justified. However, the IA would have benefited from providing greater clarity on those components that were either included in (short-term exposure limit values) or excluded (biological limit values) from the preferred options. The analysis of impacts focuses on their economic and social dimension, mainly ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

La Commissione europea sta portando avanti un processo in più fasi al fine di modificare la direttiva 2004/37/CE (direttiva sugli agenti cancerogeni e mutageni), ampliando il suo ambito di applicazione e includendo e/o rivedendo i valori limite di esposizione professionale per una serie di agenti chimici cancerogeni o mutageni. La terza proposta di modifica della direttiva riguarda cinque ulteriori agenti. L'accordo sulla proposta, raggiunto dopo i negoziati di trilogo, necessita ora di un voto di ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...